When cancer cells enter the leptomeninges, which are part of the membrane that covers the brain and spinal cord, it can turn into a type of metastasis known as leptomeningeal disease (LMD).
2022
More Study Needed on Melanoma Risk From Methotrexate
Quantifying the risk of malignant melanoma from methotrexate use proved difficult in this new study, with the authors calling for larger studies with longer follow-up to guide future practice in the space.
Study: Potential therapeutic target identified to treat melanoma
Melanoma is a highly aggressive skin cancer that frequently metastasizes, but current therapies benefit only some patients.
Jonathan S. Zager, MD, Reviews Percutaneous Hepatic Perfusion With Melphalan in Ocular Melanoma With Hepatic Metastases
At ASCO 2022, Jonathan S. Zager, MD, spoke about the phase 3 FOCUS trial which analyzed patients with hepatic-dominant ocular melanoma receiving percutaneous hepatic perfusion with melphalan or best alternative care.